Mythic Therapeutics Revenue and Competitors

Location

$126.6M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Mythic Therapeutics's estimated annual revenue is currently $3.8M per year.(i)
  • Mythic Therapeutics's estimated revenue per employee is $77,500
  • Mythic Therapeutics's total funding is $126.6M.

Employee Data

  • Mythic Therapeutics has 49 Employees.(i)
  • Mythic Therapeutics grew their employee count by 0% last year.

Mythic Therapeutics's People

NameTitleEmail/Phone
1
Founder and CSOReveal Email/Phone
2
VP Technical OperationsReveal Email/Phone
3
VP Clinical OperationsReveal Email/Phone
4
VP, LegalReveal Email/Phone
5
VP, Head Information TechnologyReveal Email/Phone
6
SVP, Head BiologyReveal Email/Phone
7
Head BiologicsReveal Email/Phone
8
Director, Human ResourcesReveal Email/Phone
9
Director, Antibody EngineeringReveal Email/Phone
10
Senior Director, Head Preclinical DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Mythic Therapeutics?

Mythic Therapeutics is a product-platform company that is pioneering a powerful new approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics. Our technology dramatically increases therapeutic potency without compromising safety, thereby unlocking the full potential of targeted therapies against a broad array of tumor targets. At Mythic, we focus on patient-centered science and are driven to leave a lasting impact on cancer care.

keywords:N/A

$126.6M

Total Funding

49

Number of Employees

$3.8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.9M49-11%N/A
#2
$13.8M49-56%N/A
#3
$3.9M5035%N/A
#4
$35M50-2%N/A
#5
$4.1M5011%N/A